RENAL PRO-DRUGS OFFER NEW PERSPECTIVES IN IMMUNOSUPPRESSIVE THERAPY

被引:0
作者
RUERS, TJM
BUURMAN, WA
VANDERLINDEN, CJ
VANDONGEN, JJ
KOOTSTRA, G
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:907 / 909
页数:3
相关论文
共 50 条
[31]   Synthesis of naproxen pro-drugs for enhanced transdermal absorption [J].
Assali, Mohyeddin ;
Zaid, Abdel Nasr ;
Abualhasan, Murad ;
Jaradat, Nidal ;
Tarayra, Rana ;
Hamdan, Aseel ;
Ardah, Rula .
Journal of Chemical and Pharmaceutical Research, 2014, 6 (08) :1-4
[32]   PRO-DRUGS FOR THE ORAL DELIVERY OF DISODIUM-CROMOGLYCATE [J].
MORI, T ;
NISHIMURA, K ;
TAMAKI, S ;
NAKAMURA, S ;
TSUDA, H ;
KAKEYA, N .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1988, 36 (01) :338-344
[33]   WHAT ARE THE MECHANISMS BY WHICH PRO-DRUGS ARE ACTIVATED IN THE BODY [J].
BUNDGAARD, H .
JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1983, 8 (02) :153-154
[34]   Synthesis and characterization of aminoacidic pro-drugs of valproic acid [J].
Giannola, LI ;
Lamartina, L ;
de Caro, V .
PHARMAZIE, 1998, 53 (12) :829-834
[35]   Towards novel pro-drugs for CNS delivery of anti-trypanosomal drugs [J].
Parveen, S. ;
Douglas, K. T. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 :S82-S83
[36]   EFFECTS OF CYSTEINE PRO-DRUGS ON ACETAMINOPHEN-INDUCED HEPATOTOXICITY [J].
HAZELTON, GA ;
HJELLE, JJ ;
KLAASSEN, CD .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1986, 237 (01) :341-349
[38]   ENHANCEMENT OF ORGANOLEPTIC AND STABILITY PROPERTIES OF ANTIBIOTICS BY USE OF PRO-DRUGS [J].
SINKULA, AA .
ACTA PHARMACEUTICA SUECICA, 1976, 13 :7-8
[39]   SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF OXOLINIC ACID PRO-DRUGS [J].
LOUBINOUX, B ;
COLIN, JL ;
THOMAS, V .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1991, 26 (04) :461-467
[40]   SOME PERSPECTIVES ON IMMUNOSUPPRESSIVE DRUGS [J].
SCHWARTZ, RS .
MEDICAL COLLEGE OF VIRGINIA QUARTERLY, 1967, 3 (02) :80-&